Humacyte annual total assets
2020
2021
2022
2023
2024
2025
Humacyte Total Assets Growth & History (HUMA)
Humacyte's total assets was $116.4M for fiscal 2025.
View full Humacyte company overviewHumacyte annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $116.4M | −$21.5M | −15.60% |
| 2024 | 2024-12-31 | $137.9M | $9.6M | +7.53% |
| 2023 | 2023-12-31 | $128.2M | −$76.1M | −37.24% |
| 2022 | 2022-12-31 | $204.3M | −$82.2M | −28.70% |
| 2021 | 2021-12-31 | $286.5M | $179.8M | +168.57% |
| 2020 | 2020-12-31 | $106.7M | — | — |
Humacyte quarterly total assets
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $138.1M | −$708,000 | −0.51% |
| Q1 2026 | 2026-03-31 | $110.6M | −$52.0M | −31.99% |
| Q4 2025 | 2025-12-31 | $116.4M | −$21.5M | −15.60% |
| Q3 2025 | 2025-09-30 | $91.5M | −$23.3M | −20.26% |
| Q2 2025 | 2025-06-30 | $138.8M | $514,000 | +0.37% |
| Q1 2025 | 2025-03-31 | $162.6M | $1.1M | +0.67% |
| Q4 2024 | 2024-12-31 | $137.9M | $9.6M | +7.53% |
| Q3 2024 | 2024-09-30 | $114.8M | −$34.6M | −23.18% |
| Q2 2024 | 2024-06-30 | $138.3M | −$29.8M | −17.74% |
| Q1 2024 | 2024-03-31 | $161.5M | −$21.5M | −11.76% |
| Q4 2023 | 2023-12-31 | $128.2M | −$76.1M | −37.24% |
| Q3 2023 | 2023-09-30 | $149.4M | −$76.8M | −33.96% |
| Q2 2023 | 2023-06-30 | $168.1M | −$78.3M | −31.77% |
| Q1 2023 | 2023-03-31 | $183.0M | −$81.5M | −30.81% |
| Q4 2022 | 2022-12-31 | $204.3M | −$82.2M | −28.70% |
| Q3 2022 | 2022-09-30 | $226.2M | −$77.1M | −25.43% |
| Q2 2022 | 2022-06-30 | $246.4M | $145.9M | +145.12% |
| Q1 2022 | 2022-03-31 | $264.5M | $163.8M | +162.71% |
| Q4 2021 | 2021-12-31 | $286.5M | $179.8M | +168.57% |
| Q3 2021 | 2021-09-30 | $303.4M | $202.0M | +199.40% |
| Q2 2021 | 2021-06-30 | $100.5M | — | — |
| Q1 2021 | 2021-03-31 | $100.7M | — | — |
| Q4 2020 | 2020-12-31 | $106.7M | — | — |
| Q3 2020 | 2020-09-30 | $101.3M | — | — |
Humacyte total assets trends
Over the last five fiscal years, Humacyte's total assets increased from $106.7M to $116.4M, a change of $9.7M. The latest reported quarter, Q2 2026, shows $138.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Humacyte source filings ↗